Genomics Medicine Ireland Nabs $40 Million and Plans to to Create 150 New Jobs
Irish life-sciences start-up Genomics Medicine Ireland is to create 150 new jobs in Ireland after raising $40 million (€36 million) in a funding round.
The company, which is working on treatments for Alzheimer’s and multiple sclerosis, said the investment will be used to establish a world-class genomic research and development programme in Dublin and to undertake comprehensive studies that will be used to improve understanding of the factors involved in disease,
Investors in the Series A funding round include the Ireland Strategic Investment Fund, ARCH Venture Partners, Polaris Partners, and GV (formerly Google Ventures).
The company, which is working on treatments for Alzheimer’s and multiple sclerosis, said the investment will be used to establish a world-class genomic research and development programme in Dublin and to undertake comprehensive studies that will be used to improve understanding of the factors involved in disease,
Investors in the Series A funding round include the Ireland Strategic Investment Fund, ARCH Venture Partners, Polaris Partners, and GV (formerly Google Ventures).